The effect of 1-NA-PP1 on 12-myristate 13-acetate (PMA)-induced endogenous PKD1 activation in LNCaP prostate cancer cells was examined as previously described [9], [23], [28]. The gene discussed is PKD1; the disease is prostate carcinoma.